Peapod Lane Capital’s Medifast MED Stock Holding History

Peapod Lane Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.36M	Buy	222,576 +3,513	+2%	+$40.5K	1.59%	25
2026 Q1	$2.21M	Buy	219,063 +117,496	+116%	+$1.27M	1.82%	20
2025 Q4	$1.08M	Buy	101,567 +13,403	+15%	+$160K	0.92%	42
2025 Q3	$1.21M	Buy	88,164 +970	+1%	+$13.5K	1.08%	43
2025 Q2	$1.23M	Buy	87,194 +17,994	+26%	+$236K	1.23%	35
2025 Q1	$933K	Buy	+69,200	New	+$1.04M	1.05%	34

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Peapod Lane Capital's MED Position: Q2 2026 in Review

Peapod Lane Capital increased its Medifast (MED) stake by 1.6% in Q2 2026, buying an estimated $40.5K and bringing the position to 222,576 shares worth $2.36M. The position accounts for 1.59% of the portfolio, ranked #25.

Peapod Lane Capital first reported a position in MED in Q1 2025 and has held it in 6 quarters since. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Peapod Lane Capital held 222,576 shares of Medifast worth $2.36M as of Q2 2026.
Peapod Lane Capital bought 3,513 Medifast shares in Q2 2026, an estimated $40.5K.
Medifast made up 1.59% of Peapod Lane Capital's portfolio in Q2 2026, its #25 holding.
Peapod Lane Capital first reported a position in Medifast in Q1 2025 and has held it in 6 quarters since.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Peapod Lane Capital's 13F filing for Q2 2026, filed 27 Jul 2026.